Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)Chromosome Aberrations, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Philadelphia Chromosome, Translocation, Genetic, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasmActive, not recruitingPhase 32026-08-26NCT05456191

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Novartis Pharmaceuticals432

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Illinois Cancer CarePeoriaUnited States21
Messino Cancer CentersAshevilleUnited States28
Oncology Hematology Care IncCincinnatiUnited States7
Regions HospitalSaint PaulUnited States290
Rocky Mountain Cancer CentersDenverUnited States26
Texas Oncology P ABedfordUnited States1
Texas Oncology PA BedfordBedfordUnited States1
Virginia Oncology AssociatesNorfolkUnited States73
Williamette Cancer CenterEugeneUnited States2